Vericel (VCEL) Acquisitions (2014 - 2019)
Vericel (VCEL) reported Acquisitions of $13.9 million for Q3 2019, down 68.75% on a YoY basis from $44.5 million in Q3 2018, and down 35.99% sequentially from $21.7 million in Q2 2019.
Vericel (VCEL) Acquisitions (2014 - 2019) Analysis & Trends
Vericel (VCEL) has 6 years of Acquisitions data on file, last reported at $13.9 million in Q3 2019.
- For the quarter ending Q3 2019, Acquisitions fell 68.75% year-over-year to $13.9 million; the trailing twelve-month figure through Sep 2019 stood at $90.8 million (up 105.36% YoY), and the FY2014 full-year result was $1.4 million, changed N/A from the prior year.
- Acquisitions declined to $13.9 million in Q3 2019, from $21.7 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $44.5 million in Q3 2018 to a low of -$2.3 million in Q4 2015.
- A 5-year average of $6.1 million and a median of $353000.0 in 2015 frame the typical range for Acquisitions.
- Across the five-year window, Acquisitions sank 213.75% in 2017 and surged 16393.04% in 2018, its largest moves.
- Tracing VCEL's Acquisitions over 5 years: stood at -$2.3 million in 2015, then soared by 43.61% to -$1.3 million in 2016, then soared by 79.22% to -$273000.0 in 2017, then surged by 16393.04% to $44.5 million in 2018, then slumped by 68.75% to $13.9 million in 2019.
- Business Quant data shows VCEL's Acquisitions at $13.9 million in Q3 2019, $21.7 million in Q2 2019, and $10.7 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 13.90 Mn |
| Jun 30, 2019 | 21.72 Mn |
| Mar 31, 2019 | 10.69 Mn |
| Sep 30, 2018 | 44.48 Mn |
| Sep 30, 2017 | -273,000.00 |
| Jun 30, 2017 | 203,000.00 |
| Mar 31, 2017 | 70,000.00 |
| Dec 31, 2016 | -1.31 Mn |
| Sep 30, 2016 | 240,000.00 |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 13,000.00 |
| Dec 31, 2015 | -2.33 Mn |
| Sep 30, 2015 | 775,000.00 |
| Jun 30, 2015 | 1.20 Mn |
| Mar 31, 2015 | 353,000.00 |
| Sep 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | -1.05 Mn |